Posts by Magali Bischof

The MedCo software, developed by EPFL and CHUV researchers, grants access to medical data from different sources while respecting the patient’s privacy.   The technology uses different cryptographic techniques, such as homomorphic encryption and private blockchain. These two technologies put together, enable to protect the personal data available while controlling the level of accessibility.  …

The Swiss Bioinformatics Institute (SBI) and the University of Manchester have published a Practical Guide to understand “basic bioinformatics approaches that can be used to understand the molecular basis of genetic diseases”.   Access the full guide

The funds, raised from private investors, will support Novostia in carrying out the first clinical trials.   Novostia has developed, in collaboration with Microcity, the University of Bern and the EPFL, a new generation of artificial heart valves.   Read full press release in English

“The Scale Up Vaud initiative continues to grow and welcomes five new members.”   Innovaud shares the outcomes and statistics of it’s Scale Up Initiative. Over 2360 jobs have been created worldwide, including 1400 based in Switzerland.   Read Innovaud’s full article in English

The Valais based startup, SimplicityBio acquired by the USA group Precision for Medicine on 6 March 2019.   Precision for Medicine announced the acquisition of SimplicityBio, adding artificial intelligence to Precision’s QuartzBio™ multiomic data integration and informatics platform.   The addition of an artificial intelligence engine to QuartzBio provides Precision’s clients the most robust, sophisticated end-to-end solution for…

“Bacteria walk (a bit) like we do”   Research at the EPFL’s Institute of BioEngineering and Global Health has been conducted to study the bacteria’s gait.   It is now possible to observe “bacterial filaments directly” which are at the root of the bacteria’s movement mechanisms. It is important to take a closer look at…

The HUG, as part of the GAPVAC (Glioma Actively Personalized Vaccine Consortium) consortium financed by the European Union, have reached a breakthrough point in their 20 years research towards a personalized vaccine against brain cancer.   Read the full article in French Research results on the Nature website in English

Nanolive SA develops a high speed, high resolution and label-free live cell imaging microscope to look instantly inside living cells in 3D!   The below movie shows T-Cells killing colon cancer cells. The images are provided by “Nanolive’s 3D Cell Explorer for 6 hrs at a frequency of 1 image every 20 seconds”.   Read full…

EPFL spin-off, Lunaphore released on 7 February 2019 it’s “rapid screening test for cancer”.   Lunaphore has acquired the CE marking for its product and will be commercializing it across Europe as of today.    “Lunaphore’s tumor analysis system LabSatTM detects and classifies tumors more quickly and reliably than existing solutions. The microfluidic system, developed through…